Literature DB >> 21501225

Relationships between blood levels of fat soluble vitamins and disease etiology and severity in adults awaiting liver transplantation.

Winsome Abbott-Johnson1, Paul Kerlin, Alan Clague, Helen Johnson, Ross Cuneo.   

Abstract

BACKGROUND AND AIMS: Although malnutrition is common in liver disease, there are limited data on fat soluble vitamins in various diseases. The aims of this study were to: (i) determine fat soluble vitamin levels in patients assessed for liver transplantation; (ii) compare levels between different disease etiologies (hepatocellular and cholestatic) and between subgroups of hepatocellular disease; and (iii) assess the multivariate contribution to vitamin levels of etiology and various indicators of disease severity.
METHODS: This was a cross-sectional study of 107 inpatients awaiting liver transplantation, mean age 47 years. Biochemical parameters included plasma retinol, 25-hydroxycholecalciferol, and vitamin E. Biochemical (albumin, bilirubin and zinc) and clinical indicators (Child-Pugh and Model of End Stage Liver Disease [MELD] scores) of disease severity were determined.
RESULTS: Deficiencies of retinol (< 1.0 µmol/L), 25-hydroxycholecalciferol (< 50 nmol/L) and vitamin E (< 11 µmol/L) were present in 75%, 66% and 3%, respectively, of patients. Concentrations of retinol and vitamin E were lower in hepatocellular than cholestatic disease but 25-hydroxycholecalciferol concentrations were similar. Child-Pugh score was higher in hepatocellular than cholestatic disease. Concentrations of retinol were lower in alcoholic liver disease (ALD) than hepatitis and Child-Pugh score was higher in ALD. For the whole group, levels of retinol, 25-hydroxycholecalciferol and vitamin E were negatively related to Child-Pugh score, MELD score and bilirubin, and positively related to albumin. When Child-Pugh scores were controlled for, retinol was lower in the hepatocellular group.
CONCLUSIONS: There was a high prevalence of fat soluble vitamin deficiencies with vitamin levels being related to disease severity. Retinol was lower in the hepatocellular group.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21501225     DOI: 10.1111/j.1440-1746.2011.06746.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  6 in total

1.  A curious case of cholestasis: oral terbinafine associated with cholestatic jaundice and subsequent erythema nodosum.

Authors:  Kartik Kumar; Anna Gill; Rachelle Shafei; Janine L Wright
Journal:  BMJ Case Rep       Date:  2014-12-05

2.  High prevalence of vitamin A deficiency and vitamin D deficiency in patients evaluated for liver transplantation.

Authors:  Mukund Venu; Eric Martin; Kia Saeian; Samer Gawrieh
Journal:  Liver Transpl       Date:  2013-04-15       Impact factor: 5.799

3.  Nutrition Support in Liver Transplantation and Postoperative Recovery: The Effects of Vitamin D Level and Vitamin D Supplementation in Liver Transplantation.

Authors:  Junshi Doi; Amika Moro; Masato Fujiki; Bijan Eghtesad; Cristiano Quintini; K V Narayanan Menon; Koji Hashimoto; Kazunari Sasaki
Journal:  Nutrients       Date:  2020-11-28       Impact factor: 5.717

4.  Prevalence and characteristics of bone disease in cirrhotic patients.

Authors:  Hale Gokcan; Meral Akdogan Kayhan; Sibel Ozbudak Demir; Sabite Kacar; Pinar Cam; Mustafa Kaplan; Rabia Daylak; Derya Oztuna; Sedef Özdal Kuran; Derya Ari
Journal:  Hepatol Forum       Date:  2020-05-21

Review 5.  Nutrition and Chronic Liver Disease.

Authors:  Rocío Aller de la Fuente
Journal:  Clin Drug Investig       Date:  2022-04-29       Impact factor: 3.580

6.  Low Levels of 25-Hydroxy Vitamin D are Independently Associated with the Risk of Bacterial Infection in Cirrhotic Patients.

Authors:  Rodolphe Anty; M Tonohouan; P Ferrari-Panaia; T Piche; A Pariente; Q M Anstee; P Gual; A Tran
Journal:  Clin Transl Gastroenterol       Date:  2014-05-29       Impact factor: 4.488

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.